Published in Curr Opin Immunol on February 09, 2010
Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 13.44
Macrophage diversity enhances tumor progression and metastasis. Cell (2010) 13.41
Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol (2012) 12.19
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science (2011) 7.95
Influence of tumour micro-environment heterogeneity on therapeutic response. Nature (2013) 4.78
The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol (2010) 4.66
The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol (2010) 3.57
CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell (2011) 3.31
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe (2013) 3.21
Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol (2011) 3.16
History of myeloid-derived suppressor cells. Nat Rev Cancer (2013) 3.14
Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med (2011) 3.12
Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst (2013) 3.07
Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol (2012) 2.94
New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape. Curr Opin Immunol (2014) 2.47
Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature (2011) 2.47
Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med (2011) 2.39
An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One (2010) 2.08
Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proc Natl Acad Sci U S A (2011) 2.08
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res (2014) 2.00
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J Clin Invest (2011) 1.90
Complexities of TGF-β targeted cancer therapy. Int J Biol Sci (2012) 1.84
Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials (2012) 1.81
TGF-β signaling in myeloid cells is required for tumor metastasis. Cancer Discov (2013) 1.76
Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel) (2014) 1.74
Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity (2011) 1.72
The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J (2015) 1.69
Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res (2011) 1.67
Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma. Curr Biol (2015) 1.58
CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8(+) T cells. Oncoimmunology (2013) 1.57
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int (2012) 1.53
Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PLoS One (2011) 1.50
An immunologic portrait of cancer. J Transl Med (2011) 1.50
Interleukin-19 increases angiogenesis in ischemic hind limbs by direct effects on both endothelial cells and macrophage polarization. J Mol Cell Cardiol (2014) 1.48
Significance of heparanase in cancer and inflammation. Cancer Microenviron (2011) 1.46
Cancer prevention by targeting angiogenesis. Nat Rev Clin Oncol (2012) 1.45
The discovery of placenta growth factor and its biological activity. Exp Mol Med (2012) 1.43
High-resolution transcriptome of human macrophages. PLoS One (2012) 1.42
Macrophage polarization in metabolic disorders: functions and regulation. Curr Opin Lipidol (2011) 1.42
A critical role for macrophages in promotion of urethane-induced lung carcinogenesis. J Immunol (2011) 1.41
Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol (2011) 1.41
Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS One (2013) 1.40
Anti-tumour strategies aiming to target tumour-associated macrophages. Immunology (2013) 1.40
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun (2016) 1.39
Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. Am J Transl Res (2012) 1.37
IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity. J Clin Invest (2013) 1.36
Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature (2013) 1.34
IL-4 in the brain: a cytokine to remember. J Immunol (2012) 1.34
The tumor-immune microenvironment and response to radiation therapy. J Mammary Gland Biol Neoplasia (2010) 1.33
Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. J Am Soc Nephrol (2013) 1.33
ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res (2013) 1.32
Curating the innate immunity interactome. BMC Syst Biol (2010) 1.30
Radiation-induced effects and the immune system in cancer. Front Oncol (2012) 1.27
The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment. Cancer Microenviron (2014) 1.24
Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest (2014) 1.24
The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol (2014) 1.22
Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. J Clin Invest (2014) 1.21
Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur J Immunol (2011) 1.20
The role IL-1 in tumor-mediated angiogenesis. Front Physiol (2014) 1.19
TLR2-dependent selective autophagy regulates NF-κB lysosomal degradation in hepatoma-derived M2 macrophage differentiation. Cell Death Differ (2012) 1.17
Dual functions of natural killer cells in selection and differentiation of stem cells; role in regulation of inflammation and regeneration of tissues. J Cancer (2012) 1.16
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival. Proc Natl Acad Sci U S A (2013) 1.16
Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design. Int J Mol Sci (2012) 1.15
The role of chemokines and their receptors in angiogenesis. Cell Mol Life Sci (2011) 1.15
Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor. J Immunol (2013) 1.15
Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis. Nat Rev Drug Discov (2015) 1.14
Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev (2016) 1.13
Tumor microenvironment in the brain. Cancers (Basel) (2012) 1.12
Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8. Mol Med (2011) 1.12
Macrophages and angiogenesis: a role for Wnt signaling. Vasc Cell (2012) 1.12
Myeloid cells in tumor inflammation. Vasc Cell (2012) 1.12
DNA alkylating therapy induces tumor regression through an HMGB1-mediated activation of innate immunity. J Immunol (2011) 1.12
Macrophages are essential for the early wound healing response and the formation of a fibrovascular scar. Am J Pathol (2013) 1.12
Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model. PLoS One (2013) 1.11
Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow. FASEB J (2013) 1.10
Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and antitumor immunity. Cancer Cell (2011) 1.10
Macrophages in injured skeletal muscle: a perpetuum mobile causing and limiting fibrosis, prompting or restricting resolution and regeneration. Front Immunol (2011) 1.08
Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol Cancer Res (2012) 1.08
CD40 immunotherapy for pancreatic cancer. Cancer Immunol Immunother (2013) 1.08
Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment. Transl Cancer Res (2012) 1.08
Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection. Gastric Cancer (2014) 1.07
Characterization of macrophage--cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer. Sci Rep (2015) 1.06
Bone marrow-derived cells serve as proangiogenic macrophages but not endothelial cells in wound healing. Blood (2011) 1.06
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils. J Exp Med (2013) 1.06
Monocytes and macrophages in cancer: development and functions. Cancer Microenviron (2012) 1.06
Alternatively activated myeloid (M2) cells enhance cognitive function in immune compromised mice. Brain Behav Immun (2010) 1.05
Targeting cancer-related inflammation: Chinese herbal medicine inhibits epithelial-to-mesenchymal transition in pancreatic cancer. PLoS One (2013) 1.05
Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy. Am J Cancer Res (2013) 1.04
High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer. PLoS One (2013) 1.04
Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. ScientificWorldJournal (2014) 1.03
Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood (2013) 1.03
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia (2013) 1.02
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1. Am J Physiol Gastrointest Liver Physiol (2012) 1.02
A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis. J Natl Cancer Inst (2014) 1.02
Transcription factor ATF3 links host adaptive response to breast cancer metastasis. J Clin Invest (2013) 1.00
Hypothesis: are neoplastic macrophages/microglia present in glioblastoma multiforme? ASN Neuro (2011) 1.00
Functions of thymic stromal lymphopoietin in immunity and disease. Immunol Res (2012) 1.00
Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs). J Biol Chem (2012) 1.00
Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene (2012) 1.00
Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences. Crit Care (2013) 1.00
Cancer-related inflammation. Nature (2008) 34.21
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85
Macrophage activation and polarization. Front Biosci (2008) 11.17
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis (2009) 7.55
Macrophage polarization comes of age. Immunity (2005) 5.67
Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol (2012) 4.30
Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev (2006) 4.02
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol (2007) 3.95
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood (2005) 3.85
Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med (2003) 3.71
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev (2008) 3.33
Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A (2009) 3.01
New vistas on macrophage differentiation and activation. Eur J Immunol (2007) 2.99
p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res (2006) 2.76
Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol (2008) 2.26
Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum Immunol (2009) 2.19
Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur J Cancer (2004) 2.12
M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. J Immunol (2009) 2.06
Pathways connecting inflammation and cancer. Curr Opin Genet Dev (2008) 1.95
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes (2002) 1.84
Cellular and molecular pathways linking inflammation and cancer. Immunobiology (2009) 1.78
Macrophage activation and polarization as an adaptive component of innate immunity. Adv Immunol (2013) 1.67
Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. Blood (2009) 1.59
Inflammation and cancer: breast cancer as a prototype. Breast (2007) 1.52
Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin Cancer Biol (2004) 1.43
Tumor promotion by tumor-associated macrophages. Adv Exp Med Biol (2007) 1.31
Divergent effects of hypoxia on dendritic cell functions. Blood (2008) 1.20
Retracted Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. Immunity (2012) 1.12
Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Novartis Found Symp (2004) 1.12
Expression of CD4 on human peripheral blood neutrophils. Blood (2003) 1.07
MiR-146a and NF-κB1 regulate mast cell survival and T lymphocyte differentiation. Mol Cell Biol (2012) 1.03
Mechanisms linking pathogens-associated inflammation and cancer. Cancer Lett (2010) 1.03
Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense. J Infect Dis (2002) 0.98
Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells. J Biol Chem (2008) 0.97
Hypoxia-mediated regulation of macrophage functions in pathophysiology. Int Immunol (2012) 0.96
Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus. Arthritis Rheum (2012) 0.93
Linking inflammation reactions to cancer: novel targets for therapeutic strategies. Adv Exp Med Biol (2008) 0.92
La mala educación of tumor-associated macrophages: Diverse pathways and new players. Cancer Cell (2010) 0.91
IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member in Trypanosoma congolense infection-resistant C57BL/6 mice. Eur J Immunol (2011) 0.90
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase. Proc Natl Acad Sci U S A (2010) 0.90
Tumor-associated macrophages and dendritic cells as prototypic type II polarized myeloid populations. Tumori (2004) 0.90
Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target. J Transl Med (2009) 0.87
Macrophages in cancer and infectious diseases: the 'good' and the 'bad'. Immunotherapy (2011) 0.84
Inactivation of junctional adhesion molecule-A enhances antitumoral immune response by promoting dendritic cell and T lymphocyte infiltration. Cancer Res (2010) 0.84
The p50 subunit of NF-κB orchestrates dendritic cell lifespan and activation of adaptive immunity. PLoS One (2012) 0.81
Tolerance in intestinal inflammation and cancer. Curr Drug Targets (2008) 0.76